BridgeMD
New treatment option for Polypharmacy
Official title Evaluation of the Impact of a Collaboration Between Hospital and Community Pharmacists at Hospital Discharge
ClinicalTrials.gov ID: NCT06902779
What this study is testing
- What it's testing
- The aim of this study is to evaluate the impact of an enhanced collaboration between a hospital pharmacist and a community pharmacist during hospital discharge. For patients taking multiple medications, hospitalization often involves numerous changes to their treatment regimen.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients admitted to the internal medicine ward for more than 48 hours
- Patients prescribed seven or more drugs at the time of screening
- Patients discharged to home
- Patients able to give informed consent as documented by signature
You likely can't join if
- Patient discharged to another hospital, nursing home or rehabilitation clinic
- Refusal of the community pharmacy to participate
- Inability to sign consent and follow the procedures of the study, due to language problems, psychological disorders, dementia, alterations of...
The study team makes the final eligibility decision.
Where it's taking place
- Rennaz, Canton of Vaud, Switzerland
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rennaz, Canton of Vaud, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.